Literature DB >> 12944027

Treatment with amlodipine and atorvastatin have additive effect in improvement of arterial compliance in hypertensive hyperlipidemic patients.

Eyal Leibovitz1, Maya Beniashvili, Reuven Zimlichman, Angela Freiman, Marina Shargorodsky, Dov Gavish.   

Abstract

BACKGROUND: This study investigates the effect of amlodipine on arterial compliance (AC), and the effect of atorvastatin on AC when given in combination with amlodipine.
METHODS: Twenty-one consecutive hypertensive hyperlipidemic patients were included in this study. Patients were followed every month for 6 months (3 months of amlodipine therapy and 3 months of amlodipine and atorvastatin combination).
RESULTS: During the 3 months of amlodipine monotherapy, large and small AC were improved by 26% and 38%, respectively, and the systemic vascular resistance was reduced by 10%. The addition of atorvastatin during the next 3 months improved small AC by an additional 42% and decreased the systemic vascular resistance by another 5%, but large AC and blood pressure did not change.
CONCLUSIONS: Amlodipine improves large and small AC, and the beneficial effect of atorvastatin on small AC is additive to the effect achieved by amlodipine.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12944027     DOI: 10.1016/s0895-7061(03)00949-x

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  13 in total

Review 1.  Scientific rationale for combination of a calcium channel antagonist and an HMG-CoA reductase inhibitor: a new approach to risk factor management.

Authors:  R Preston Mason
Journal:  Drugs       Date:  2008       Impact factor: 9.546

2.  Synergistic effect of amlodipine and atorvastatin on blood pressure, left ventricular remodeling, and C-reactive protein in hypertensive patients with primary hypercholesterolemia.

Authors:  Chang-Jiang Ge; Shu-Zheng Lu; Yun-Dai Chen; Xiao-Fan Wu; Shen-Jiang Hu; Ying Ji
Journal:  Heart Vessels       Date:  2008-04-04       Impact factor: 2.037

Review 3.  Heart failure in the twenty-first century: is it a coronary artery disease or hypertension problem?

Authors:  Raghava S Velagaleti; Ramachandran S Vasan
Journal:  Cardiol Clin       Date:  2007-11       Impact factor: 2.213

Review 4.  Amlodipine/Atorvastatin: a review of its use in the treatment of hypertension and dyslipidaemia and the prevention of cardiovascular disease.

Authors:  Monique P Curran
Journal:  Drugs       Date:  2010       Impact factor: 9.546

5.  Fixed-dose combination therapy--is it time for this approach to hypertension and dyslipidemia management?

Authors:  Domenic A Sica
Journal:  J Clin Hypertens (Greenwich)       Date:  2004-04       Impact factor: 3.738

6.  Patient adherence and preference considerations in managing cardiovascular risk: focus on single pill and amlodipine/atorvastatin fixed combination.

Authors:  Farhan Aslam; Attiya Haque; Veronica Lee; Joanne Foody
Journal:  Patient Prefer Adherence       Date:  2009-11-03       Impact factor: 2.711

7.  Basal and post-ischemic vascular compliance in children/adolescents born small for gestational age.

Authors:  Mirella Strambi; Gianluca Messa; Silvia Berni; Serena Capitani; Andrea Pammolli; Francesca Iacoponi; Costantina Censurato; Caroline Magne Tene; Alessandro Fiorica; Aurelio Vittoria
Journal:  Pediatr Nephrol       Date:  2012-05-10       Impact factor: 3.714

Review 8.  Fixed combination of amlodipine and atorvastatin in cardiovascular risk management: patient perspectives.

Authors:  Madhuri Devabhaktuni; Sripal Bangalore
Journal:  Vasc Health Risk Manag       Date:  2009

9.  Modulation of calcification of vascular smooth muscle cells in culture by calcium antagonists, statins, and their combination.

Authors:  Astrid Trion; Cindy Schutte-Bart; Wilhelmina H Bax; J Wouter Jukema; Arnoud van der Laarse
Journal:  Mol Cell Biochem       Date:  2007-10-02       Impact factor: 3.396

10.  Effects of single pill-based combination therapy of amlodipine and atorvastatin on within-visit blood pressure variability and parameters of renal and vascular function in hypertensive patients with chronic kidney disease.

Authors:  Kengo Azushima; Kazushi Uneda; Kouichi Tamura; Hiromichi Wakui; Masato Ohsawa; Ryu Kobayashi; Toru Dejima; Tomohiko Kanaoka; Akinobu Maeda; Yoshiyuki Toya; Satoshi Umemura
Journal:  Biomed Res Int       Date:  2014-04-08       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.